Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Schouw & Co. share buy-back programme, week 1 2024
-
ROSEN, THE FIRST FILING FIRM, Encourages Blue Ridge Bankshares, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – BRBS
-
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
-
Dassault Aviation: Total number of shares and voting rights - 31 12 23
-
AAMI and FDA Co-Sponsor Medtech Conference, ‘AAMI and FDA neXus'
-
Epiq Selected by Taft to Drive Operational Innovation
-
Sanford Heisler Sharp Names Thiru Vignarajah Baltimore Office Managing Partner
-
CoNextions Medical Receives Innovative Technology Contract from Vizient for the CoNextions TR® Tendon Repair System
-
Form 8.3 - Irish Residential Properties REIT plc
-
HARP Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Harpoon Therapeutics to Merck
-
Net Asset Value(s)
-
HARP Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Harpoon Therapeutics to Merck
-
EPOW’s CEO Purchased 245,000 Shares of the Company’s Ordinary Shares
-
Janover Launches its Insurtech Startup, Janover Insurance Group
-
Janover Launches its Insurtech Startup, Janover Insurance Group
-
Accanto Health appoints seasoned behavioral healthcare leader as CEO
-
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
-
Live from CES: Verizon announces latest exclusive deals from new content partners
-
Tecogen Launches Self-Learning Intelligent Control for Cogeneration Systems
-
Revolutionary Carotid Artery Device Focused on Saving Lives
-
Form 8.3 - LXi REIT plc
-
Form 8.3 - Smart Metering Systems plc
-
Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers
-
Inimmune Corporation and Intrommune Therapeutics announce a collaboration to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy for the treatment of peanut allergy
-
Focused Compounding Fund, LP Issues Open Letter to the Board of Parks! America, Inc.
-
PubMatic Leads the Way in Adopting Addressability Alternatives, Delivering Monetization Benefits for Publishers
-
Smokey Bones Turns Back the Clock to 1999
-
Form 8.3 - musicMagpie plc
-
AMAM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Ambrx Biopharma to Johnson & Johnson
-
AMAM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Ambrx Biopharma to Johnson & Johnson
-
Form 8.3 - LondonMetric Property plc
-
Eastern Mountain Sports Says “Hike Off!” to Screaming Pundits with New Politics Escape Pack
-
Biomea Fusion Announces Dosing of First Type 1 Diabetes Patient in Phase II Study (COVALENT-112) with BMF-219
-
Megerian Rugs & Carpet Cleaning Celebrates a Century of Offering Traditional Rug and Carpet Care
-
Urbanimmersive Announces Resignation of Ghislain Lemire and Marc Blackburn as Directors
-
EAB Partners with Mantra Health to Connect College Students with Proven Mental Health Support
-
Outlook Dental McKinney Launch Emergency Dental Services to Offer Patients Immediate, Comprehensive Care
-
Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance
-
Excelitas Technologies Acquires Heraeus Noblelight, Strengthening its Position in Global Specialty Lighting Markets
-
Kriya Provides Update on Pipeline Progress Ahead of Company Presentation at 42nd Annual J.P. Morgan Healthcare Conference
-
Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
-
Fields Cannary Webinar Recap Available
-
Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
-
HealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor Day
-
VIVUS Provides Update on Pipeline and Program Milestones
-
Vibrant, High-Quality Neon Signs, NeonXpert Announce New Design Options for its Custom Neon Signs
-
Muscular Dystrophy Association Announces 2024 National Ambassador Ira Walker
-
Fields Cannary Webinar Recap Available
-
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
-
MGP Promotes Amel Pasagic to Chief Commercial Officer
